Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic ... weeks. Participants also lost 12 to 15 pounds in clinical trials, though it’s not a weight loss ...

Mounjaro vs. Ozempic: Which Is Better for Weight Loss? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re ...

and led to a weight loss of about 10% over 26 weeks in people with obesity, improving blood pressure and levels of circulating fatty molecules. Like Ozempic, orforglipron is a GLP-1 receptor ...

The maintenance dose of Ozempic for weight loss is usually 1.0 mg per week. Some individuals may require an increase to 2.0 mg if recommended by their healthcare provider. Always adhere to the ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Game-changing weight loss jabs relied on by millions of slimmers ... The drugs, which include Mounjaro, Ozempic and Wegovy, have ushered in a new era in the battle against obesity, helping dieters ...